~2 spots leftby Apr 2026

Fetoscopic Surgery for Spina Bifida

Recruiting in Palo Alto (17 mi)
+1 other location
RQ
RC
Overseen byRamen Chmait, MD
Age: 18+
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: USFetus
Disqualifiers: Diabetes, Obesity, Hypertension, HIV, others
No Placebo Group
Approved in 2 Jurisdictions

Trial Summary

What is the purpose of this trial?

The purpose of this study is to evaluate the feasibility of a fetoscopic surgical technique for antenatal correction of fetal myelomeningocele. Two surgical approaches will be utilized. The percutaneous approach will be offered to participants with a posterior placenta. The laparotomy/uterine exteriorization approach will be offered to participants regardless of placental location.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Fetoscopy, Fetoscopic surgery, Percutaneous endoscopic correction, Minimally invasive fetoscopic repair for Spina Bifida?

Research shows that minimally invasive fetoscopic surgery for spina bifida can improve neurological outcomes for babies and reduce the need for postnatal surgery, while also minimizing risks to the mother compared to open fetal surgery. The fetoscopic approach is evolving, with improvements in delivery outcomes and potential benefits similar to open surgery.12345

Is fetoscopic surgery for spina bifida generally safe for humans?

Fetoscopic surgery for spina bifida is designed to minimize risks to the mother compared to open fetal surgery, with careful management to ensure safety for both mother and fetus. Studies have shown that with proper anesthetic management and surgical techniques, risks such as preterm birth, anesthesia complications, and maternal trauma can be reduced.16789

How is fetoscopic surgery for spina bifida different from other treatments?

Fetoscopic surgery for spina bifida is a minimally invasive procedure that aims to repair the condition before birth, reducing the need for postnatal neurosurgery and minimizing risks to the mother compared to traditional open fetal surgery. This approach avoids large incisions, leading to a quicker recovery for the mother and potentially better neurological outcomes for the baby.123910

Research Team

RQ

Ruben Quintero, MD

Principal Investigator

Wellington Regional Medical Center

RC

Ramen Chmait, MD

Principal Investigator

University of Southern California/ Huntington Memorial Hospital

Eligibility Criteria

This trial is for pregnant women over 18 with a fetus diagnosed with myelomeningocele, between 19-27 weeks' gestation. They must be able to stay near Wellington or Pasadena for the pregnancy and delivery, and return for follow-ups. Exclusions include multiple pregnancies, certain health conditions like HIV/Hepatitis-B, obesity (BMI of 35+), nickel allergy, pregestational diabetes, uterine anomalies, previous early deliveries.

Inclusion Criteria

Willingness to remain in the greater Wellington or Pasadena area (within a 30-minute car ride) for remainder of the pregnancy and deliver at Wellington Regional Medical Center or Huntington Memorial Hospital for postnatal management
I can come back for check-ups at 12, 24, 30, 48, and 60 months.
My test results confirm a balanced karyotype, acceptable through FISH if I'm 24 weeks along or more.
See 5 more

Exclusion Criteria

I want to have surgery for my baby's spina bifida before birth at this hospital.
The mother has a medical condition that makes surgery or anesthesia unsafe.
Participation in another intervention study influencing maternal and fetal morbidity and mortality
See 20 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo fetoscopic surgical correction of myelomeningocele using either laparotomy or percutaneous techniques

Up to 21 weeks
Surgery and follow-up assessments until delivery

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Fetoscopy (Procedure)
Trial OverviewThe study tests a fetoscopic surgical technique versus traditional surgery to correct fetal myelomeningocele before birth. The percutaneous approach is used if the placenta is at the back; otherwise laparotomy/uterine exteriorization can be done regardless of placental location.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Fetoscopic repairExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

USFetus

Lead Sponsor

Trials
2
Recruited
120+

Wellington Hospital

Collaborator

Trials
11
Recruited
1,500+

University of Southern California

Collaborator

Trials
956
Recruited
1,609,000+
Dr. Samir A. profile image

Dr. Samir A.

University of Southern California

Chief Executive Officer since 2024

PhD in Molecular Biology from the University of Southern California

Dr. Chung profile image

Dr. Chung

University of Southern California

Chief Medical Officer since 2016

MD from UC San Diego

Findings from Research

A minimally invasive fetoscopic approach for closing spina bifida aperta in two fetuses resulted in successful neural cord coverage and avoided the need for postnatal neurosurgery, demonstrating its efficacy.
Both neonates showed significant improvements, including reversal of hindbrain herniation and satisfactory leg, bladder, and bowel function, indicating the potential for this technique to enhance outcomes compared to traditional methods.
Percutaneous fetoscopic patch closure of human spina bifida aperta: advances in fetal surgical techniques may obviate the need for early postnatal neurosurgical intervention.Kohl, T., Tchatcheva, K., Merz, W., et al.[2018]
Prenatal repair of open spina bifida through fetoscopic techniques shows promise in reducing shunt rates and improving postnatal neurological outcomes, comparable to traditional open surgery.
The laparotomy-based fetoscopic approach has been associated with fewer complications and higher gestational ages at delivery compared to the percutaneous method, which is still being refined to improve outcomes.
Endoscopic fetal surgery for neural tube defects.Lapa, DA.[2020]
The fetoscopic surgical approach for repairing myelomeningocele resulted in significantly better maternal and neonatal outcomes compared to the open approach, including fewer cases of preterm birth, neonatal death, and neurodevelopmental disabilities in both the index and subsequent pregnancies.
Although the fetoscopic technique was more expensive, it was deemed cost-effective, with an incremental cost-effectiveness ratio of $1029 per quality-adjusted life year, indicating that the improved outcomes justify the higher costs in a theoretical cohort of 500 women.
Fetoscopic compared with open repair of myelomeningocele: a 2-delivery cost-effectiveness analysis.Packer, CH., Hersh, AR., Caughey, AB.[2021]

References

[Peri- and postoperative management for minimally invasive fetoscopic surgery of spina bifida]. [2014]
Percutaneous fetoscopic patch closure of human spina bifida aperta: advances in fetal surgical techniques may obviate the need for early postnatal neurosurgical intervention. [2018]
Endoscopic fetal surgery for neural tube defects. [2020]
Fetoscopic compared with open repair of myelomeningocele: a 2-delivery cost-effectiveness analysis. [2021]
Implementation Process and Evolution of a Laparotomy-Assisted 2-Port Fetoscopic Spina Bifida Closure Program. [2021]
Peri-operative management of percutaneous fetoscopic spina-bifida repair: a descriptive review of five cases from the United Kingdom, with focus on anaesthetic implications. [2021]
Laparotomy-Assisted 2-Port Fetoscopic Repair of Spina Bifida Aperta: Report of a Single-Center Experience in Paris, France. [2023]
Anesthetic Management for Percutaneous Minimally Invasive Fetoscopic Surgery of Spina Bifida Aperta: A Retrospective, Descriptive Report of Clinical Experience. [2018]
Percutaneous/mini-laparotomy fetoscopic repair of open spina bifida: a novel surgical technique. [2022]
Percutaneous fetoscopic patch coverage of spina bifida aperta in the human--early clinical experience and potential. [2006]